279 filings
10-Q
2019 Q3
ALPN
Alpine Immune Sciences Inc
Quarterly report
14 Nov 19
4:03pm
8-K
ALPN
Alpine Immune Sciences Inc
13 Nov 19
Alpine Immune Sciences Provides Corporate Update and Reports Third Quarter 2019 Financial Results
4:24pm
8-K
ALPN
Alpine Immune Sciences Inc
28 Aug 19
Entry into a Material Definitive Agreement
9:02am
10-Q
2019 Q2
ALPN
Alpine Immune Sciences Inc
Quarterly report
13 Aug 19
4:34pm
8-K
ALPN
Alpine Immune Sciences Inc
13 Aug 19
Reports Second Quarter 2019 Financial Results
7:32am
8-K
unys738 cf
17 Jun 19
Submission of Matters to a Vote of Security Holders
5:04pm
4
860kff bf
3 Jun 19
ALPINE IMMUNE SCIENCES / James Paul Rickey ownership change
8:00am
8-K
go8m vvzue18
24 May 19
Termination of a Material Definitive Agreement
7:42am
8-K
cc4myp8ju1iza4brymgz
15 May 19
Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products
8:31am
8-K
ygsgj5tzpg4788nt
9 May 19
Reports First Quarter 2019 Financial Results
8:11am
DEFA14A
wm4g4rx3u vk3jx9onc
24 Apr 19
Additional proxy soliciting materials
5:27pm
8-K
uzt7e
18 Apr 19
Alpine Immune Sciences Appoints Stanford Peng to President and Head of Research and Development
4:31pm
PRE 14A
5rm4 ebyd
11 Apr 19
Preliminary proxy
4:29pm
424B3
6avov yvo
5 Apr 19
Prospectus supplement
8:53am
EFFECT
v8vs410f t9nbb
5 Apr 19
Notice of effectiveness
12:17am
CORRESP
dlqse7p it735tejhx
2 Apr 19
Correspondence with SEC
12:00am
8-K
rdxwybr74a0f2pj
1 Apr 19
Departure of Directors or Certain Officers
4:16pm
CT ORDER
uiowky0f0
29 Mar 19
Confidential treatment order
12:00am